2025 ANNUAL REPORT
A Letter from the President & CEO
As I reflect on 2025, I am filled with tremendous pride not only in what The Geneva Foundation accomplished, but in the remarkable people and partnerships that made it possible.
Military medicine advances because researchers, clinicians, military leaders, industry, academia, and federal partners come together with a shared purpose: delivering innovations that protect the health, readiness, and resilience of those who serve. Geneva is honored to stand at the center of that collaboration, providing the expertise, infrastructure, and trusted partnership needed to transform promising ideas into real-world impact for our nation's warfighters.
Throughout this report, you will see the stories that define 2025. They reflect meaningful progress across some of the military's most pressing medical challenges, from reducing musculoskeletal injuries and advancing battlefield trauma care to expanding access to critical care in operational environments. They also highlight the investigators whose scientific leadership drives discovery, the employees whose dedication makes that work possible every day, and the partners whose collaboration enables innovation to move farther and faster.
This year also marked an important chapter in Geneva's evolution. We celebrated outstanding achievements across our research enterprise, welcomed new scientific leaders whose expertise will help shape our future, and expressed our gratitude to those whose service has strengthened our organization and our mission. These moments remind us that sustained impact is built through exceptional people working together in pursuit of something greater than themselves.
While I am proud of what Geneva accomplished in 2025, I am even more energized by what lies ahead. The pace of change in military medicine continues to accelerate, bringing new challenges, new opportunities, and an even greater responsibility to innovate. Geneva remains committed to strengthening the partnerships, advancing the research, and delivering the operational excellence required to ensure military medical discoveries translate into meaningful outcomes for those who defend our nation.
To our sponsors, investigators, collaborators, employees, Board members, Scientific Advisory Board, and the many partners who place their trust in Geneva—thank you. Your commitment makes this work possible. Together, we are advancing military medicine, strengthening military readiness, and improving the lives of those who serve.
Elise W. Huszar, MBA
President & Chief Executive Officer
The Geneva Foundation
Advancing Military Medicine: Delivering Research Outcomes
Geneva delivered research projects across priority areas critical to military health and operational readiness. This work improved care delivery, shortened recovery timelines, and strengthened performance, accelerating the implementation of new capabilities into the Military Health System.
Advancing Concussion Recovery Decisions
Objective eye-response measurements may help clinicians assess concussion recovery and support safe return-to-duty decisions.
Informing Readiness Through Injury Data
Researchers quantify the burden of head and neck injuries to support military healthcare planning and readiness.
Improving Survival After Severe Trauma
Researchers identify potential therapeutic targets to reduce organ failure and improve outcomes after traumatic hemorrhage.
Enabling Care in Austere Environments
Miniaturized extracorporeal technology may bring critical respiratory support closer to injured Warfighters.
Forging Ahead: New Research Projects in 2025
In 2025, Geneva expanded its research with new projects focused on emerging threats to force health. These efforts build the next generation of solutions in survivability, rehabilitation, and performance, strengthening future operational capability for Service members and the communities they serve.
| Award Title | Award Amount | Award Number |
| Holistic Health and Fitness (H2F) Program | $10,552,536 | P000050584 |
| A Randomized, Blinded, Placebo-Controlled Dose-Ranging Study to Evaluate and Characterize the Efficacy of Remdesivir | $8,045,432 | 801641511 |
| Development of Patient-Matched Segmental Defect Implant System with Mechanobiologic Activation and Antimicrobial Coating for Treatment of Severe Fractures | $4,817,413 | HT94252510464 |
| Immunogenicity and Efficacy Bridging Study of V920 in Cynomolgus Macaques | $2,293,842 | C38649-V4 |
| Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) | $2,457,000 | HU00012520064 |
| Autonomous Unmanned Resuscitation and Oxygen Research for Austere Operations (AURORA) | $2,350,000 | FY26.891.001 |
| Blood Transfusion Optimization (BTO) | $2,298,585 | HU0001262E010 |
| Extracorporeal Immunomodulation to Reduce Inflammation After Severe Burns, Inhalation Injury, and Septicemia | $2,198,698 | HT9425-25-1-0549 |
| Investigating Massage Therapy as a Modality in Patients with Sub-Acute Lower Back Pain | $1,695,258 | HU00012520022 |
| Blast Overpressure Exposure Longitudinal Study (BLES) | $1,467,911 | HU00012520052 |
Programs of Impact
Geneva is advancing priority capabilities for military medicine through its major programs of impact.
Researchers at the Center for Biotechnology (4D Bio3) developed a low-cost, high-efficiency tool that facilitates the cutting and management of organoids during extended culture periods. A recent publication, “An Efficient Organoid Cutting Method for Long-Term Culture and High-Throughput Analyses," introduced a simple, sterile cutting system that helps maintain organoid health and scalability.
This innovation will enable faster, large-scale analysis to accelerate precision medicine, improving recovery and the long-term health of Service members.
Researchers at Geneva's Autonomous Reanimation and Evacuation (AREVA) Research Institute led a new study titled "Anticoagulate the Circuit, Not the Patient: Nitric Oxide Reduces Thrombus Formation During Extracorporeal Carbon Dioxide Removal" investigating whether nitric oxide (NO), known for its anti-clotting properties, could be used within the extracorporeal circuit, rather than the patient's bloodstream, to reduce clotting during extracorporeal carbon dioxide removal.
This approach could significantly expand the safety and utility of extracorporeal support in patients where anticoagulation poses unacceptable risk, improving critical care and survivability in complex military medical environments.
The Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) Program led a global initiative to standardize injury research and boost readiness for Service members.
The "Reporting of Musculoskeletal Injuries in the Military" (ROMMIL) initiative brought together more than 100 experts form the U.S., U.K., Canada, Australia, New Zealand, Belgium, and other allied nations to unify how injuries are studied and reported.
As the initiative moves forward, it provides the global military community with the means to measure injury accurately and consistently to ultimately support force readiness and generate cost savings by reducing injury burden.
Researchers with the Research for Combat Casualty Care Operations Network (REC3ON) published a new study that is helping shape trauma care practices in operational environments. Focusing on Negative Pressure Wound Therapy (NPWT), the team addressed a critical challenge in battlefield medicine: safely and effectively managing these devices during aeromedical evacuation and transport in austere settings.
The research led to the development of practical tools and training resources that enhance provider readiness, reduce complications during transit, and improve survival outcomes for injured Service members.
Awards & Recognition
Neil Vining, MD, MBA, recognized for his service to Geneva
Neil Vining, MD, concluded more than a decade of service to The Geneva Foundation, leaving a lasting impact on the organization’s mission to advance military medicine. First supported by Geneva as an active-duty researcher during his orthopedic surgery residency at Madigan Army Medical Center, Dr. Vining later joined the Scientific Advisory Board in 2012, serving as Chair from 2016 to 2020. He joined the Board of Directors in 2018 and served as Board Chair from 2021 to 2024.
Throughout his tenure, Dr. Vining played a pivotal role in shaping Geneva’s scientific priorities and strategic growth, helping strengthen the organization’s position as a trusted partner in military medical research. Drawing on his experience as both an enlisted Warfighter and Army orthopedic trauma surgeon, he championed research that improves survivability, readiness, and long-term health outcomes for Service members. His leadership guided Geneva through a period of significant growth, including its 30th anniversary milestone and the expansion of partnerships across military, academic, and industry communities, creating a legacy that will continue to influence military medicine for years to come.
Dallas C. Hack, MD, MPH, FACMPH, COL (Ret) concluded his service on Geneva’s Scientific Advisory Board after years of distinguished leadership in military medicine. A nationally recognized expert in combat casualty care, operational medicine, and military medical readiness, Dr. Hack brought extensive experience as a physician, researcher, and military leader to Geneva’s scientific oversight and strategic direction. His insights helped ensure that scientific priorities remained aligned with the needs of Warfighters and military healthcare providers, supporting research efforts that improve survivability, enhance readiness, and advance the future of combat casualty care. His service leaves a lasting influence on Geneva’s mission and its commitment to delivering research that addresses the most pressing challenges facing military medicine.
Geneva welcomed Dr. Paul Bliese, Dr. Mark Kortepeter, and Dr. Candy Wilson to its Scientific Advisory Board in 2025. Their extensive experience in military medicine, research, and healthcare leadership strengthens Geneva’s scientific guidance and supports continued alignment with evolving military health priorities.
Paul D. Bliese, PhD, COL (Ret)
A nationally recognized expert in behavioral health, leadership, and organizational performance, Dr. Bliese spent more than two decades as a research psychologist at the Walter Reed Army Institute of Research. His expertise in workforce readiness, psychological health, and research methodology provides valuable insight into the human dimensions of military readiness.
Mark G. Kortepeter, MD, MPH, COL (Ret)
Dr. Kortepeter brings extensive expertise in biodefense, infectious diseases, and military medical research, including leadership roles at the U.S. Army Medical Research Institute of Infectious Diseases and the Uniformed Services University. His experience supports Geneva’s efforts to address emerging global health and force health protection challenges.
Candy Wilson, PhD, MHSc, MSN, APRN, WHNP-BC, FAANP, FAAN, COL (Ret), USAF
A distinguished military nurse scientist and healthcare leader, Dr. Wilson has dedicated her career to advancing evidence-based practice, nursing research, and military health systems. Her expertise in clinical care, research translation, and healthcare leadership strengthens Geneva’s efforts to improve health outcomes and operational readiness.
Teryn R. Roberts, PhD, Recognized as Geneva's 2024 Researcher of the Year
Teryn R. Roberts, PhD, was recognized as Geneva’s 2024 Researcher of the Year for her exceptional contributions to extracorporeal life support (ECLS) research and combat casualty care. As an investigator with the Autonomous Reanimation and Evacuation (AREVA) Research Institute & Innovation Center, Dr. Roberts has led efforts to improve the safety and effectiveness of ECLS through innovative coagulation management strategies and the development of blood-compatible biomaterials for critically injured patients.
Her research is advancing deployable solutions that have the potential to improve outcomes in austere and operational environments, helping inform future clinical protocols for Warfighters and critically ill patients. In addition to her scientific achievements, Dr. Roberts is committed to mentoring junior investigators, technicians, and students, helping cultivate the next generation of military medical researchers.
Generating Economic Impact Through Military Medical Research
Geneva translated federal research investment into measurable economic impact across key regions, driving job creation, workforce expansion, and national defense outcomes.
Total Economic Impact in the U.S.
Procured Goods & Services
Annual Wages & Benefits
Team Geneva: A Mission-Ready Workforce
342 Employees in the U.S.
83% Program, 17% Corporate
31 States Where Geneva Employees Live and Work
Across 46 Military and Federal Performance Sites
Celebrating Excellence
The Wave the Flag award recognizes employees who demonstrate excellence in mission execution and embody Geneva’s core values: innovation, quality, superior customer service, integrity, teamwork, and respect for all. The individuals awarded in 2025 represent the standard required to deliver results in support of Department of War priorities.
.png "Robert Edwards (1)")
Worldwide Impact
Geneva’s operations enabled the execution of military medical research at scale, delivering programs across clinical and operational environments where outcomes are validated and applied. Our network provided access to military populations, increased the speed of study execution, and ensured that research translated into capability that will improve survivability, restore readiness, and enhance performance across the force.
Funding of Active Projects in 2025
Investigators Worldwide
Research Projects
Research Sites (MHS, Federal, Collaborator)
Trusted by Federal Sponsors
Federal sponsors entrusted Geneva to execute research programs addressing critical military medical challenges and priorities, leveraging operational expertise, regulatory knowledge, and collaborative networks to translate research into mission-relevant outcomes.
Advanced Research Projects Agency for Health (ARPA-H)
Air Force Material Command (USAF/AFMC)
Army Medical Research and Material Command (AMRMC)
Army Small Business Innovation Research (SBIR)
Biomedical Advanced Research and Development Authority (BARDA)
Congressionally Directed Medical Research Program (CDMRP)
Defense Advanced Research Projects Agency (DARPA)
Defense Health Agency (DHA)
Defense Medical Research and Development Program (DMRDP)
Defense Threat Reduction Agency (DTRA)
Department of Veterans Affairs (VA)
Medical Technology Enterprise Consortium (MTEC)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institutes of Health (NIH)
Navy Bureau of Medicine and Surgery (BUMED)
Office of Naval Research (ONR)
TriService Nursing Research Program (TSNRP)
UK Defence Science and Technology Laboratory (DSTL)
Uniformed Services University of the Health Sciences (USUHS)
United States Army Medical Materiel Development Activity (USAMMDA)
United States Army Medical Research Acquisition Activity (USAMRAA)
United States Army Medical Research and Development Command (USAMRDC)
United States Army Medical Research and Materiel Command (USAMRMC)
United States Department of Health and Human Services (HHS)
United States Department of War (DoW)
Integrated Networks Advancing Military Medical Capability
Geneva’s collaborators span government, academia, industry, and nonprofit institutions to extend the reach of military medical research, ensuring access to specialized expertise and environments.
Advanced Bioprocess Services
ATTUNE Neurosciences, Inc
Baylor University
Boeth Analytics, LLC
Cannon Design, Inc
Circulogene Theranostics, LLC
Cornell University
Digital Health Outcomes
Duke University
Emovi, Inc
Empatica, Inc
Endeavor Health Clinical Operations
Ensodata, Inc
FIBRENX, LLC
Florida Atlantic University
Fred Hutchinson Cancer Center
High Point University
Huxley Medical, Inc
ICF Incorporated
Indiana University
Insum Solutions Corp
INTERAXON, Inc
Johns Hopkins University
KBR Wyle, Inc
Kennel and Associates, Inc
Kessler Foundation
Lawrence Livermore National Security, LLC
Leidos, Inc
Level 42 AI, Inc
Lviv Territorial Medical Union
Maryland Technology Development Corporation
Mayo Clinic
MCRA, LLC
MedStar Health Research Institute
MESO Scale Diagnostics, LLC
Michigan State University
Mission First Solutions, LLC
Movella, Inc
MyCardio, LLC
NERVGEN Pharma Corp
New Mexico Institute of Mining Technology
Nightware
Novogene Corporation
Odessa National Medical University
Odyssey Systems
Pacific Lutheran University
PHARPOINT Research, Inc
POINTCROSS, Inc
PPD, part of Thermo Fisher Scientific
PROPHARMA Group, LLC
Purdue University
QACV Consulting
Research Foundation of SUNY
RingTail Labs, LLC
Rockwood Company, LLC
Safi Biotherapeutics, Inc
Sciperio, Inc.
Shupyk National Healthcare University of Ukraine
SiOxMed
Stumptown Research & Development, LLC
Texas A&M University System
Texas Woman's University
The Catholic University of America
The Cleveland Clinic
The General Hospital Corp
The George Washington University
The Heart Institute of the Ministry of Health of Ukraine
The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc
The Metis Foundation
The Spaulding Rehabilitation Hospital Corp
TRIARI Pharmaceuticals, Inc
University of Alabama at Birmingham
University of California
University of Chicago
University of Colorado
University of Georgia
University of Illinois
University of Iowa
University of Kansas
University of Miami
University of Minnesota
University of Missouri
University of North Carolina at Chapel Hill
University of North Carolina at Greensboro
University of Texas at San Antonio
University of Texas Health Science Center at San Antonio (UTHSCSA)
University of the Incarnate Word
University of Utah
University of Washington
UPMC Community Medicine, Inc
Utah State University
Uzhhorod Municipal Clinic Center and Affiliated Hospital
Vanderbilt University Medical Center
Veterans Education & Research Associates of North New England, Inc
Virginia Polytechnic Institute and State University
Wake Forest University
Western Michigan University
Xtory, Inc
Yale University
ZEEL Networks, Inc